337
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Screening for latent tuberculosis infection in South Korean healthcare workers using a tuberculin skin test and whole blood interferon-γ assay

, , , , , , , & show all
Pages 672-678 | Received 02 Dec 2009, Accepted 06 Apr 2010, Published online: 20 May 2010

References

  • Menzies D, Fanning A, Yuan L, Fitzgerald M. Tuberculosis among health care workers. N Engl J Med 1995;332:92–8.
  • Skodric V, Savic B, Jovanovic M, Pesic I, Videnovic J, Zugic V, . Occupational risk of tuberculosis among health care workers at the Institute for Pulmonary Diseases of Serbia. Int J Tuberc Lung Dis 2000;4:827–31.
  • Kruuner A, Danilovitsh M, Pehme L, Laisaar T, Hoffner SE, Katila ML. Tuberculosis as an occupational hazard for health care workers in Estonia. Int J Tuberc Lung Dis 2001;5:170–6.
  • Jiamjarasrangsi W, Hirunsuthikul N, Kamolratanakul P. Tuberculosis among health care workers at King Chulalongkorn Memorial Hospital, 1988–2002. Int J Tuberc Lung Dis 2005;9:1253–8.
  • Jo KW, Woo JH, Hong Y, Choi CM, Oh YM, Lee SD, . Incidence of tuberculosis among health care workers at a private university hospital in South Korea. Int J Tuberc Lung Dis 2008;12:436–40.
  • Centers for Disease Control and Prevention. Guidelines for prevention of TB transmission in hospital. Publication No. CDC82–8371. Atlanta, GA: US Department of Health and Human Services, Public Health Service; 1982.
  • International Union Against Tuberculosis and Lung Disease, World Health Organization. Control of tuberculosis transmission in health care settings. Tuber Lung Dis 1994;75:94–5.
  • Kantor HS, Poblete R, Pusateri SL. Nosocomial transmission of tuberculosis from unsuspected disease. Am J Med 1988; 84:833–8.
  • Haley CE, McDonald RC, Rossi L, Jones WD Jr, Haley RW, Luby JP. Tuberculosis epidemic among hospital personnel. Infect Control Hosp Epidemiol 1989;10:204–10.
  • Jereb JA, Klevens RM, Privett TD, Smith PJ, Crawford JT, Sharp VL, . Tuberculosis in health care workers at a hospital with an outbreak of multidrug-resistant Mycobacterium tuberculosis. Arch Intern Med 1995;155:854–9.
  • Sepulveda RL, Ferrer X, Latrach C, Sorensen RU. The influence of Calmette–Guerin bacillus immunization on the booster effect of tuberculin testing in healthy young adults. Am Rev Respir Dis 1990;142:24–8.
  • Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993;17:968–75.
  • Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of bacille Calmette–Guerin vaccination on tuberculin skin test measurements. Thorax 2002;57:804–9.
  • Jensen PA, Lambert LA, Iademarco MF, Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005;54:1–141.
  • National Institute for Health and Clinical Excellence. Tuberculosis. Clinical diagnosis and management of tuberculosis and measures for its prevention and control. Clinical Guideline 33. London, UK: NICE; 2009. Available at: http://guidance. nice.org.uk/CG33/Guidance/pdf/English (accessed September 2009).
  • World Health Organization. Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009. WHO/HTM/TB 2009.411. Geneva, Switzerland: WHO; 2009.
  • Kim SJ, Lee SH, Kim IS, Kim HJ, Kim SK, Rieder HL. Risk of occupational tuberculosis in National Tuberculosis Programme laboratories in Korea. Int J Tuberc Lung Dis 2007; 11:138–42.
  • Lee K, Han MK, Choi HR, Choi CM, Oh YM, Lee SD, . Annual incidence of latent tuberculosis infection among newly employed nurses at a tertiary care university hospital. Infect Control Hosp Epidemiol 2009;30:1218–22.
  • Public Health Weeky Report, Korea Center for Disease Control. Analysis of notified tuberculosis patients in 2007, Korea. KCDC: Korea; 2007. Available at: http://www.cdc.go.kr/kcdchome/jsp/home/information/had/INFOHAD0001Detail.jsp?menuid=100053&appid=kcdchome&content=/contents/information/had/b/4440_view.html (accessed September 2009).
  • Korean National Tuberculosis Association. Tuberculosis. KNTA: Korea. Available at: http://www.knta.or.kr/ (accessed September 2009).
  • Targeted tuberculin testing and treatment of latent tuberculosis infection. This Official Statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America (IDSA), September 1999, and the sections of this Statement as it relates to infants and children were endorsed by the American Academy of Pediatrics (AAP), August 1999. Am J Respir Crit Care Med 2000;161:S221–47.
  • Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004;4:761–76.
  • Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 2006;27:442–8.
  • Vinton P, Mihrshahi S, Johnson P, Jenkin GA, Jolley D, Biggs BA. Comparison of QuantiFERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection. Infect Control Hosp Epidemiol 2009; 30:215–21.
  • Choi JC, Shin JW, Kim JY, Park IW, Choi BW, Lee MK. The effect of previous tuberculin skin test on the follow-up examination of whole-blood interferon-gamma assay in the screening for latent tuberculosis infection. Chest 2008;133: 1415–20.
  • Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, . Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 2005;293:2746–55.
  • Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, . Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005;293:2756–61.
  • Pollock NR, Campos-Neto A, Kashino S, Napolitano D, Behar SM, Shin D, . Discordant QuantiFERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution? Infect Control Hosp Epidemiol 2008;29:878–86.
  • Lalvani A. Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment? Clin Infect Dis 2004;38:757–9.
  • van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, Juritz J, . Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am J Respir Crit Care Med 2009;180:49–58.
  • Centers for Disease Control and Prevention. Tuberculosis. Atlanta: CDC. Available at: http://www.cdc.gov/tb/publications/factsheets/default.htm (accessed March 2010).
  • Eum SY, Lee YJ, Kwak HK, Min JH, Hwang SH, Via LE, . Evaluation of the diagnostic utility of a whole-blood interferon-gamma assay for determining the risk of exposure to Mycobacterium tuberculosis in bacille Calmette–Guerin (BCG)-vaccinated individuals. Diagn Microbiol Infect Dis 2008;61:181–6.
  • Menzies D, Joshi R, Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 2007;11:593–605.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.